Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
Neurology|May 1, 1996
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PETJ Tedroff, M Pedersen, S M Aquilonius, et al.Neuroscience|August 1, 1992
Monoamine oxidase-B in motor cortex: changes in amyotrophic lateral sclerosisJ Ekblom, S S Jossan, P G Gillberg, et al.Acta Neurologica Scandinavica|March 1, 1992
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyJ Tedroff, S M Aquilonius, P Hartvig, et al.Archives of Toxicology|January 1, 1992
Receptor alterations in manganese intoxicated monkeysH Eriksson, P G Gillberg, S M Aquilonius, et al.Acta Neurologica Scandinavica|September 9, 2005
Objective assessment of cervical dystonia: a pilot studyL Zetterberg, K Halvorsen, C Färnstrand, et al.Journal of the Neurological Sciences|April 15, 1999
Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosisE Grundström, H Askmark, J Lindeberg, et al.Journal of Neural Transmission. General Section|January 1, 1992
Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiographyS M Aquilonius, S S Jossan, J G Ekblom, et al.British Journal of Clinical Pharmacology|March 1, 1993
The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in manH Lennernäs, D Nilsson, S M Aquilonius, et al.Acta Neurologica Scandinavica|April 8, 1998
Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's diseaseD Nilsson, L E Hansson, K Johansson, et al.Pageof 10